Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: A systematic review

被引:31
作者
Ghazali, Naseem [1 ,2 ]
Shaw, Richard J. [1 ,2 ]
Rogers, Simon N. [1 ,3 ]
Risk, Janet M. [2 ]
机构
[1] Aintree Univ Hosp NHS Fdn Trust, Reg Maxillofacial Unit, Liverpool L9 7AL, Merseyside, England
[2] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Canc Studies, Liverpool L69 3GA, Merseyside, England
[3] Edge Hill Univ, Fac Hlth, Evidence Based Res Practice Ctr, Omskirk, Lancs, England
关键词
Head and neck cancer; Radiotoxicity; Radiotherapy; Toxicity; Genetic polymorphism; Genetic association study; Single nucleotide polymorphism; SINGLE NUCLEOTIDE POLYMORPHISMS; QUALITY-OF-LIFE; DNA-REPAIR GENES; RADIATION-THERAPY; CANCER-PATIENTS; MOLECULAR MARKERS; INTERMEDIATE RISK; PROSTATE-CANCER; ASSOCIATION; RADIOSENSITIVITY;
D O I
10.1016/j.oraloncology.2012.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Interindividual variations in radiotoxicity responses exist despite uniform treatment protocols. It is speculated that normal genetic variants, particularly single nucleotide polymorphisms (SNPs) may influence normal head and neck (HN) tissue radiotoxicity. This first-ever systematic review was undertaken to evaluate the association of SNPs with normal HN tissues radiotoxicity. Multiple databases (1950-February 2012) were reviewed using a combination of related keywords and MeSH terms. All published HN radiotoxicity studies with sufficient relevant data for extraction were included. The outcomes evaluated were acute and late radiotoxicity endpoints. Methodological quality assessment based on the STrengthening the REporting of Genetic Association (STREGA) statement was performed. Seven articles from 692 articles searched fulfilled the eligibility criteria. Recruited sample sizes were small (range, 32-140). There were 5/7 case-control studies. All studies used multimodality treatment with heterogeneous radiation parameters. Candidate gene approach was used in all studies. Fourteen SNPs from 9 genes were evaluated from the following pathways: DNA damage response, radiation fibrogenesis and oxidative/xenobiotic metabolism. Acute radiotoxicity events were associated with SNPs of DNA repair genes (OR, 3.01-4.08). SNPs of TGF beta 1 were associated with osteoradionecrosis (OR, 4.2) and subcutaneous fibrosis. Genetic association studies in HN radiotoxicity currently provide hypothesis-generating findings that require validation in larger studies. Future studies must incorporate critical methodological issues and technological improvements, including using a genome-wide approach. Headway is possible through case-pooling of existing clinical trial data which could create a larger sample size of well-characterized treatment and endpoints. Also, on-going HN cancer clinical trials should consider extending their toxicity evaluation to include genetic association studies. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1090 / 1100
页数:11
相关论文
共 50 条
  • [31] Hypoglossal Nerve Upper Airway Stimulator Implantation after Radiotherapy for Head and Neck Malignancy
    Zheng, Zhong
    Hu, Shirley
    Chernobilsky, Boris
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2017, 157 (01) : 160 - 161
  • [32] Risk prediction models for dysphagia after radiotherapy among patients with head and neck cancer: a systematic review and meta-analysis
    Pu, You
    Yang, Jin
    Shui, Lian
    Tang, Qianlong
    Zhang, Xianqin
    Liu, Guangguo
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [33] Genetic variants associated with mandibular osteoradionecrosis following radiotherapy for head and neck malignancy
    Brooker, Rachel C.
    Antczak, Philipp
    Liloglou, Triantafillos
    Risk, Janet M.
    Sacco, Joseph J.
    Schache, Andrew G.
    Shaw, Richard J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 165 : 87 - 93
  • [34] A systematic review of validated assessments methods for head and neck lymphedema
    Arends, Coralie R.
    Lindhout, Josephine E.
    van der Molen, Lisette
    Wilthagen, Erica A.
    van den Brekel, Michiel W. M.
    Stuiver, Martijn M.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (06) : 2653 - 2661
  • [35] LATE ESOPHAGEAL TOXICITY AFTER RADIATION THERAPY FOR HEAD AND NECK CANCER
    Chen, Allen M.
    Li, Bao-Qing
    Jennelle, Richard L. S.
    Lau, Derick H.
    Yang, Claus C.
    Courquin, Jean
    Vijayakumar, Srinivasan
    Purdy, James A.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2010, 32 (02): : 178 - 183
  • [36] ADVANCEMENT IN RADIOTHERAPY FOR HEAD AND NECK CANCER MANAGEMENT: A REVIEW
    Korde, M.
    Jain, R.
    Sapate, R.
    Shinde, L.
    WORLD CANCER RESEARCH JOURNAL, 2023, 10
  • [37] Does adaptive radiotherapy for head and neck cancer favorably impact dosimetric, clinical, and toxicity outcomes?: A review
    Simopoulou, Foteini
    Kyrgias, George
    Georgakopoulos, Ioannis
    Avgousti, Rafaela
    Armpilia, Christina
    Skarlos, Pantelis
    Softa, Vasiliki
    Theodorou, Kiki
    Kouloulias, Vassilis
    Zygogianni, Anna
    MEDICINE, 2024, 103 (26) : e38529
  • [38] Biomarkers of normal tissue toxicity after pelvic radiotherapy
    Henson, Caroline C.
    Ang, Yeng S.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2012, 6 (01) : 33 - 40
  • [39] Efficacy and toxicity of FLASH radiotherapy: A systematic review
    Omyan, Gilnaz
    Musa, Ahmed Eleojo
    Shabeeb, Dheyauldeen
    Akbardoost, Niloofar
    Gholami, Somayeh
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (06) : 1203 - 1209
  • [40] Can Intensity-Modulated-Radiotherapy Reduce Toxicity in Head and Neck Squamous Cell Carcinoma?
    van der Veen, Julie
    Nuyts, Sandra
    CANCERS, 2017, 9 (10)